Search Results - "Graab, Ulrike"
-
1
Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma
Published in Cancer letters (01-09-2013)“…Highlights • PI3K inhibitor PI103 and MEK inhibitor U0126 synergize to trigger apoptosis in RMS. • PI103 and U0126 converge to block PI3K/mTOR and ERK…”
Get full text
Journal Article -
2
Oncogenic RAS Mutants Confer Resistance of RMS13 Rhabdomyosarcoma Cells to Oxidative Stress-Induced Ferroptotic Cell Death
Published in Frontiers in oncology (22-06-2015)“…Recent genomic studies revealed a high rate of recurrent mutations in the RAS pathway in primary rhabdomyosarcoma (RMS) samples. In the present study, we…”
Get full text
Journal Article -
3
Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma
Published in Oncotarget (20-04-2015)“…We previously reported that aberrant HH pathway activation confers a poor prognosis in rhabdomyosarcoma (RMS). Searching for new treatment strategies we…”
Get full text
Journal Article -
4
PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cells
Published in PloS one (31-12-2012)“…We searched for a drug capable of sensitization of sarcoma cells to doxorubicin (DOX). We report that the dual PI3K/mTOR inhibitor PI103 enhances the efficacy…”
Get full text
Journal Article -
5
Arsenic trioxide induces Noxa-dependent apoptosis in rhabdomyosarcoma cells and synergizes with antimicrotubule drugs
Published in Cancer letters (28-10-2016)“…Highlights • ATO reduces cell viability and clonogenic survival and triggers apoptosis in RMS cells. • ATO upregulates Noxa, which is required for ATO-induced…”
Get full text
Journal Article